Women in UK to be offered drug on NHS that halts the recurrence of breast cancer

We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info

Abemaciclib, made by Eli Lilly, cuts the chance of the disease coming back once a tumour has been removed. It is suitable for those with hormone receptor-positive early breast cancer who have had surgery.

Results from a clinical trial showed those on abemaciclib who had hormone therapy had a 30 percent greater chance of being cancer-free if they had surgery too.

Charity Breast Cancer Now welcomed the move by the National Institute for Health and Care Excellence (Nice) to offer women the drug.

Source: Read Full Article